SCHEMBL8932641

SCHEMBL8932641

Cc1c(CN2CCOCC2)c2ccccc2n1C(=O)c1cccc(Cl)c1Cl

nearest known ligand 0.83

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 16/20 0.83
CNR1 P21554 15/20 0.83
TP53 P04637 1/20 0.63
CYP3A4 P08684 1/20 0.63
HPGD P15428 1/20 0.63
ALOX15 P16050 1/20 0.63
TSHR P16473 1/20 0.63
MTOR P42345 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
TDP1 Q9NUW8 1/20 0.63
CYP2A13 Q16696 1/20 0.48
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9090895 0.94 CNR2 (0.77) CNR2CNR1TP53CYP3A4HPGD
SCHEMBL8932619 0.87 CNR1 (1.00) CNR2CNR1SMN1; SMN2
SCHEMBL8932661 0.86 CNR2 (1.00) CNR2CNR1TP53CYP3A4HPGD
SCHEMBL9088862 0.83 CNR2 (0.87) CNR2CNR1TP53CYP3A4HPGD
SCHEMBL8932634 0.81 CNR2 (0.88) CNR2CNR1TP53CYP3A4HPGD
SCHEMBL2833584 0.80 CNR2 (0.85) CNR2CNR1TP53CYP3A4HPGD
SCHEMBL27796092 0.79 CNR2 (0.62) CNR2CNR1TP53CYP3A4HPGD
SCHEMBL1165250 0.79 CNR2 (0.62) CNR2CNR1TP53CYP3A4HPGD
SCHEMBL10068291 0.78 CNR2 (0.82) CNR2CNR1TP53CYP3A4HPGD
SCHEMBL29426317 0.78 CNR2 (1.00) CNR2CNR1TP53CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996025397-A1 INDOLE DERIVATIVES WITH AFFINITY FOR THE CANNABINOID RECEPTOR MERCK FROSST CANADA INC. (CA) 1996-08-22 WO disclosed
US-5532237-A INTRAOCULAR FOR TREATMENT OF GLAUCOMA MERCK FROSST CANADA, INC. (CA) 1996-07-02 US disclosed